Instrument Inactif

Autres langues CEREP Euronext Paris

Actions

FR0004042232

Recherche biotechnologique et médicale

Cours en clôture Euronext Paris
- ^EUR	-

25/08	Lotus Bakeries, le spéculoos le plus cher de la bourse européenne
30/04	Eurofins-Cerep SA publie ses résultats annuels pour l'exercice clos le 31 décembre 2025	CI

Autres langues

26/08	Lotus Bakeries, de duurste speculoos op de Europese beurs
26/08	Lotus Bakeries, la galleta más cara de la bolsa europea
25/08	Lotus Bakeries: Der teuerste Spekulatius der europäischen Börse
25/08	Lotus Bakeries, the most expensive speculoos on the (stock) market in Europe
30/04	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025
02/10/25	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025
18/09/25	Eurofins Cerep : annonce ses résultats du 1er semestre 2025
30/04/25	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2024
03/04/25	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2024
15/05/24	Game(don't)Stop y Spéculoos
30/04/24	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2023
24/08/23	Lo sapevi? Société des Chemins de Fer et Tramways du Var et du Gard
30/04/23	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022
12/04/23	Eurofins Cerep : annonce ses résultats 2022
30/07/22	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022
12/04/22	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2021
16/04/21	Global markets live: Daimler, GSK, Mattel
23/12/20	Eurofins Cerep : Launches PCR COVID-19 Self-Test In Germany, Spain
24/09/20	Eurofins-Cerep Sa Reports Earnings Results for the Half Year Ended June 30, 2020
30/07/18	Eurofins Cerep SA acquired KVI-Plusz.
03/08/15	Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, completed the acquisition of a majority stake in Bioaccess S.A.
17/06/15	Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, agreed to acquire majority stake in Bioaccess S.A. for €225 million.
31/12/13	Eurofins-Panlabs, Inc. completed the acquisition of Cerep Inc. from Cerep SA.
13/12/13	Eurofins-Panlabs, Inc. agreed to acquire Cerep Inc. from Cerep SA for $0.27 million.
31/03/13	Eurofins Discovery Services Lux Holding completed the acquisition of 8.48% stake in Cerep SA from Thierry Jean.